Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China. // Journal of Clinical Virology. – URL: https://www.sciencedirect.com/science/article/pii/S1386653226000971?dgcid=rss_sd_all
Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China. Journal of Clinical Virology. https://www.sciencedirect.com/science/article/pii/S1386653226000971?dgcid=rss_sd_all
“Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China.” Journal of Clinical Virology.
@article{article52948,
title = {Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China},
journal = {Journal of Clinical Virology},
url = {https://www.sciencedirect.com/science/article/pii/S1386653226000971?dgcid=rss_sd_all}
}